Signaling through
NF-kappaB has been implicated in the malignant phenotype as well as the chemoresistance of various
cancers. Here we show that the natural compounds
acetyl-beta-boswellic acid and
acetyl-11-keto-beta-boswellic acid (AKbetaBA) inhibit proliferation and elicit cell death in chemoresistant
androgen-independent PC-3
prostate cancer cells in vitro and in vivo. Induction of apoptosis was demonstrated in cultured PC-3 cells by several parameters including mitochondrial
cytochrome c release and DNA fragmentation. At the molecular level these compounds inhibit constitutively activated
NF-kappaB signaling by intercepting the
IkappaB kinase (IKK) activity; signaling through the
interferon-stimulated response element remained unaffected, suggesting specificity for IKK inhibition. The impaired phosphorylation of p65 and the reduced nuclear translocation of
NF-kappaB proteins were associated with down-regulation of the constitutively overexpressed and
NF-kappaB-dependent antiapoptotic
proteins Bcl-2 and Bcl-x(L). In addition, expression of
cyclin D1, a crucial cell cycle regulator, was reduced as well. Down-regulation of IKK by antisense
oligodeoxynucleotides confirmed the essential role of IKK inhibition for the proliferation of the PC-3 cells. Both compounds tested were active in vivo, yet AKbetaBA proved to be far superior. Indeed, topical application of water-soluble AKbetaBA-
gamma-cyclodextrin on PC-3
tumors xenografted onto chick chorioallantoic membranes induced concentration-dependent inhibition of proliferation as well as apoptosis. Similarly, in nude mice carrying PC-3
tumors, systemic application of AKbetaBA-
gamma-cyclodextrin inhibited
tumor growth and triggered apoptosis in the absence of detectable systemic toxicity. Thus, AKbetaBA and related compounds acting on IKK might provide a novel approach for the treatment of chemoresistant human
tumors such as
androgen-independent human
prostate cancers.